Economic evaluation of a person-centred care intervention in head and neck oncology: results from a randomized controlled trial

Hanna Gyllensten, Ingalill Koinberg, Eric Carlström, Lars-Eric Olsson, Elisabeth Hansson Olofsson, Hanna Gyllensten, Ingalill Koinberg, Eric Carlström, Lars-Eric Olsson, Elisabeth Hansson Olofsson

Abstract

Purpose: Head and neck cancer and its treatment deteriorate quality of life, but symptoms improve with person-centred care. We examined the cost-effectiveness of a person-centred care intervention versus standard medical care.

Methods: In this randomized clinical trial of a person-centred intervention, patients were planned for outpatient oncology treatment in a Swedish university hospital between 2012 and 2014 and were followed during 1 year. Annual healthcare costs were identified from medical records and administrative register data. Productivity costs were calculated from reported sick leave. Health-related quality of life was collected using the EuroQol Group's five-dimension health state questionnaire.

Results: Characteristics were similar between 53 patients in the intervention group and 39 control patients. The average total cost was Euro (EUR) 55,544 (95% confidence interval: EUR 48,474-62,614) in the intervention group and EUR 57,443 (EUR 48,607-66,279) among controls, with similar health-related quality of life.

Conclusions: This person-centred intervention did not result in increased costs and dominated the standard medical care.

Trial registration: ClinicalTrials.gov (registration number: NCT02982746).

Keywords: Head and neck neoplasms; Health care costs; Patient care management; Person-centred care; Randomized controlled trial.

Conflict of interest statement

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the Regional Ethics Committee in Gothenburg (Ref. 025-12). Informed consent was obtained from all individual participants included in the study.

Figures

Fig. 1
Fig. 1
Study flow diagram
Fig. 2
Fig. 2
Distribution of costs over time after inclusion in the study, for patients in the intervention group and controls (2014 values)

References

    1. Rettig EM, D’Souza G. Epidemiology of head and neck cancer. Surg Oncol Clin N Am. 2015;24:379–396. doi: 10.1016/j.soc.2015.03.001.
    1. GBD 2015 Mortality and Causes of Death Collaborators Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1459–1544. doi: 10.1016/S0140-6736(16)31012-1.
    1. Beran M (2016) Nationellt vårdprogram huvud- och halscancer [National care programme for head and neck cancer]. Regional Cancer Center West. . Accessed 01/31 2017
    1. Nelke KH, Pawlak W, Gerber H, Leszczyszyn J. Head and neck cancer patients’ quality of life. Adv Clin Exp Med. 2014;23:1019–1027. doi: 10.17219/acem/37361.
    1. Ganzer H, Touger-Decker R, Byham-Gray L, Murphy BA, Epstein JB. The eating experience after treatment for head and neck cancer: a review of the literature. Oral Oncol. 2015;51:634–642. doi: 10.1016/j.oraloncology.2015.04.014.
    1. Farhangfar A, Makarewicz M, Ghosh S, Jha N, Scrimger R, Gramlich L, Baracos V. Nutrition impact symptoms in a population cohort of head and neck cancer patients: multivariate regression analysis of symptoms on oral intake, weight loss and survival. Oral Oncol. 2014;50:877–883. doi: 10.1016/j.oraloncology.2014.06.009.
    1. Hammerlid E, Silander E, Hornestam L, Sullivan M. Health-related quality of life three years after diagnosis of head and neck cancer—a longitudinal study. Head Neck. 2001;23:113–125. doi: 10.1002/1097-0347(200102)23:2<113::AID-HED1006>;2-W.
    1. Larsson M, Hedelin B, Athlin E. A supportive nursing care clinic: conceptions of patients with head and neck cancer. Eur J Oncol Nurs. 2007;11:49–59. doi: 10.1016/j.ejon.2006.04.033.
    1. Carlström ED, Hansson Olofsson E, Olsson LE, Nyman J, Koinberg IL. The unannounced patient in the corridor: trust, friction and person-centered care. Int J Health Plann Manag. 2017;32(1):e1–e16. doi: 10.1002/hpm.2313.
    1. Ekman I, Swedberg K, Taft C, Lindseth A, Norberg A, Brink E, Carlsson J, Dahlin-Ivanoff S, Johansson IL, Kjellgren K, Liden E, Ohlen J, Olsson LE, Rosen H, Rydmark M, Sunnerhagen KS. Person-centered care--ready for prime time. Eur J Cardiovasc Nurs. 2011;10:248–251. doi: 10.1016/j.ejcnurse.2011.06.008.
    1. Drummond MF, Schwartz JS, Jonsson B, Luce BR, Neumann PJ, Siebert U, Sullivan SD. Key principles for the improved conduct of health technology assessments for resource allocation decisions. Int J Technol Assess Health Care. 2008;24:244–258. doi: 10.1017/S0266462308080343.
    1. Young D, Xiao CC, Murphy B, Moore M, Fakhry C, Day TA. Increase in head and neck cancer in younger patients due to human papillomavirus (HPV) Oral Oncol. 2015;51:727–730. doi: 10.1016/j.oraloncology.2015.03.015.
    1. Hansson Olofsson E, Carlström E, Olsson LE, Nyman J, Koinberg I. Can a person-centred-care intervention improve health-related quality of life in patients with head and neck cancer? A randomized, controlled study. BMC Nurs. 2017;21(16):9. doi: 10.1186/s12912-017-0206-6.
    1. Swedish Association of Local Authorities and Regions (2016) Information om prisindex LPI och LPIK [Information about the healthcare inflation indices LPI and LPIK]. . Accessed 14 Oct 2016
    1. Krol M, Brouwer W, Rutten F. Productivity costs in economic evaluations: past, present, future. Pharmacoeconomics. 2013;31:537–549. doi: 10.1007/s40273-013-0056-3.
    1. Jacobson JJ, Epstein JB, Eichmiller FC, Gibson TB, Carls GS, Vogtmann E, Wang S, Murphy B. Head neck Oncol 4:15–3284-4-15. 2012. The cost burden of oral, oral pharyngeal, and salivary gland cancers in three groups: commercial insurance, Medicare, and Medicaid; p. 15.
    1. Statistics Sweden (2016) Statistikdatabasen: Genomsnittlig grundlön, kronor efter sektor, yrkesgrupper (SSYK 2012), kön, ålder och år [Statistical database: average wage, SEK by sector, occupational group (SSYK 2012), sex, age, and year). . Accessed 12 Aug 2016
    1. Swedish Tax Agency (2014) Tax statistical yearbook of Sweden 2014 [table 7.35: Compulsory social security contributions by age groups 2015. Employees] SKV 152, edition 17:1–328
    1. Rabin R, Gudex C, Selai C, Herdman M. From translation to version management: a history and review of methods for the cultural adaptation of the EuroQol five-dimensional questionnaire. Value Health. 2014;17:70–76. doi: 10.1016/j.jval.2013.10.006.
    1. Sveriges Riksbank (2016) Annual average exchange rates (aggregate) 2014 Jan-Dec. . Accessed 14 Dec 2016
    1. Barber JA, Thompson SG. Analysis of cost data in randomized trials: an application of the non-parametric bootstrap. Stat Med. 2000;19:3219–3236. doi: 10.1002/1097-0258(20001215)19:23<3219::AID-SIM623>;2-P.
    1. Dolan P, Roberts J. Modelling valuations for Eq-5d health states: an alternative model using differences in valuations. Med Care. 2002;40:442–446. doi: 10.1097/00005650-200205000-00009.
    1. Burström K, Sun S, Gerdtham UG, Henriksson M, Johannesson M, Levin LA, Zethraeus N. Swedish experience-based value sets for EQ-5D health states. Qual Life Res. 2014;23:431–442. doi: 10.1007/s11136-013-0496-4.
    1. White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30:377–399. doi: 10.1002/sim.4067.
    1. Faria R, Gomes M, Epstein D, White IR. A guide to handling missing data in cost-effectiveness analysis conducted within randomised controlled trials. Pharmacoeconomics. 2014;32:1157–1170. doi: 10.1007/s40273-014-0193-3.
    1. Larsson M, Hedelin B, Athlin E. Needing a hand to hold: lived experiences during the trajectory of care for patients with head and neck cancer treated with radiotherapy. Cancer Nurs. 2007;30:324–334. doi: 10.1097/01.NCC.0000281722.56996.07.
    1. Lang H, France E, Williams B, Humphris G, Wells M. The psychological experience of living with head and neck cancer: a systematic review and meta-synthesis. Psychooncology. 2013;22:2648–2663. doi: 10.1002/pon.3343.
    1. Blanchard P, Volk RJ, Ringash J, Peterson SK, Hutcheson KA, Frank SJ. Assessing head and neck cancer patient preferences and expectations: a systematic review. Oral Oncol. 2016;62:44–53. doi: 10.1016/j.oraloncology.2016.09.008.
    1. Heijnen BJ, Speyer R, Kertscher B, Cordier R, Koetsenruijter KW, Swan K, Bogaardt H (2016) Dysphagia, speech, voice, and trismus following radiotherapy and/or chemotherapy in patients with head and neck carcinoma: review of the literature. Biomed Res Int 2016:6086894
    1. Gillison ML, Chaturvedi AK, Anderson WF, Fakhry C. Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma. J Clin Oncol. 2015;33:3235–3242. doi: 10.1200/JCO.2015.61.6995.
    1. Steuer CE, El-Deiry M, Parks JR, Higgins KA, Saba NF. An update on larynx cancer. CA Cancer J Clin. 2017;67(1):31–50. doi: 10.3322/caac.21386.
    1. de Leeuw J, Larsson M. Nurse-led follow-up care for cancer patients: what is known and what is needed. Support Care Cancer. 2013;21:2643–2649. doi: 10.1007/s00520-013-1892-6.
    1. van der Meulen IC, May AM, de Leeuw JR, Koole R, Oosterom M, Hordijk GJ, Ros WJ. Long-term effect of a nurse-led psychosocial intervention on health-related quality of life in patients with head and neck cancer: a randomised controlled trial. Br J Cancer. 2014;110:593–601. doi: 10.1038/bjc.2013.733.
    1. Wells M, Semple CJ, Lane C. A national survey of healthcare professionals’ views on models of follow-up, holistic needs assessment and survivorship care for patients with head and neck cancer. Eur J Cancer Care (Engl) 2015;24:873–883. doi: 10.1111/ecc.12285.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi